PSCR (Proto Script Pharmaceutical) Selling, General, & Admin. Expense: $1.32 Mil (TTM As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical Selling, General, & Admin. Expense?

Proto Script Pharmaceutical PSCR Selling, General, & Admin. Expense is $1.32 Mil as of Sep. 2017.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Proto Script Pharmaceutical's selling, general, & admin. expense for the three months ended in Sep. 2017 was $0.30 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Sep. 2017 was $1.32 Mil.


Proto Script Pharmaceutical  (OTCPK:PSCR) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Proto Script Pharmaceutical Selling, General, & Admin. Expense Related Terms


Proto Script Pharmaceutical Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Selling, General, & Admin. Expense Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Selling, General, & Admin. Expense
0.03 0.03 0.03 0.05 0.03

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.38 0.37 0.27 0.30

PSCR vs EXCC, NXES, PRZM: Selling, General, & Admin. Expense Comparison

For the Specialty Business Services subindustry, Proto Script Pharmaceutical's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proto Script Pharmaceutical Selling, General, & Admin. Expense vs Business Services Industry

For the Business Services industry and Industrials sector, Proto Script Pharmaceutical's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Proto Script Pharmaceutical's Selling, General, & Admin. Expense falls into.



Proto Script Pharmaceutical Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Sep. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of $1.32 Mil mean?
Proto Script Pharmaceutical (PSCR) has a Selling, General, & Admin. Expense of $1.32 Mil as of Sep. 2017. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Selling, General, & Admin. Expense too high?
Proto Script Pharmaceutical's current Selling, General, & Admin. Expense is $1.32 Mil.
How does Proto Script Pharmaceutical's Selling, General, & Admin. Expense compare to EXCC and NXES?
Proto Script Pharmaceutical's Selling, General, & Admin. Expense of $1.32 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Business Services company?
A good Selling, General, & Admin. Expense depends on the Business Services industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Proto Script Pharmaceutical and its competitors. Proto Script Pharmaceutical's current Selling, General, & Admin. Expense is $1.32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Selling, General, & Admin. Expense of $1.32 Mil. The current Selling, General, & Admin. Expense is $1.32 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Selling, General, & Admin. Expense is $1.32 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.